Innovation
Access
Available Technologies
Contact Us
Innovation
Access
Available Technologies
Contact Us
Request Information
Download PDF
Permalink
Print
This technology is currently not available for licensing
Tech ID: 29314
Share This
Additional Technologies by these Inventors
Method of Preventing Bone Loss and Periodontal Disease
Multi-Target Inhibitors for Pain Treatment
Improved Dioxin Detection and Measurement
Detection System for Small Molecules
Nanoparticles for Drug Delivery, Tissue Targeting and Imaging Analysis
Small Molecule sEH Inhibitors to Treat Alpha-Synuclein Neurodegenerative Disorders
Soluble Epoxide Hydrolase-Conditioned Stem Cells for Cardiac Cell-Based Therapy
Beneficial Effects of Novel Inhibitors of Soluble Epoxide Hydrolase as Adjuvant Treatment for Cardiac Cell-Based Therapy
Antibodies: Bacillus Delta Endotoxin PAbs
Antibodies: Bromacil Herbicide PAbs
Multifunctional Porphyrin-Based Nanomedicine Platform
Novel Neuropathy Treatment Using Soluble Epoxide Inhibitors
Novel and Specific Inhibitors of p21
Novel Leukemia Stem Cell-Targeting Peptides and Nanotherapeutics for Human Leukemia Treatment
Antibodies for Pseudomonas (P.) aeruginosa
Antibodies: Urea Herbicide Pabs
Bioavailable Dual sEH/PDE4 Inhibitor for Inflammatory Pain
Chemical Synthesis of Lipid Mediator 22-HDoHE and Structural Analogs
Antibodies: Triazine Herbicide Pabs
Optimized Non-Addictive Biologics Targeting Sodium Channels Involved In Pain Signaling
Soluble Epoxide Hydrolase Inhibitors For The Treatment Of Arrhythmogenic Cardiomyopathy And Related Diseases
A New Pharmaceutical Therapy Target for Depression and Other Central Nervous System Diseases